EA201992569A1 - METHODS AND COMPOSITIONS FOR TREATING APNEA IN SLEEP - Google Patents

METHODS AND COMPOSITIONS FOR TREATING APNEA IN SLEEP

Info

Publication number
EA201992569A1
EA201992569A1 EA201992569A EA201992569A EA201992569A1 EA 201992569 A1 EA201992569 A1 EA 201992569A1 EA 201992569 A EA201992569 A EA 201992569A EA 201992569 A EA201992569 A EA 201992569A EA 201992569 A1 EA201992569 A1 EA 201992569A1
Authority
EA
Eurasian Patent Office
Prior art keywords
compositions
methods
sleep
treating apnea
treating
Prior art date
Application number
EA201992569A
Other languages
Russian (ru)
Inventor
Д. Эндрю Уэллман
Луиджи Таранто-Монтемурро
Original Assignee
Дзе Брихэм Энд Уимен'З Хоспитал, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Дзе Брихэм Энд Уимен'З Хоспитал, Инк. filed Critical Дзе Брихэм Энд Уимен'З Хоспитал, Инк.
Priority claimed from PCT/US2018/029518 external-priority patent/WO2018200775A1/en
Publication of EA201992569A1 publication Critical patent/EA201992569A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Physiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Способы и композиции для лечения состояний, связанных с коллапсом глоточных мышц дыхательных путей, при которых субъект находится в состоянии неполного сознания, например апноэ во сне и храпа, включающие введение ингибитора обратного захвата норэпинефрина (NRI) и антагониста мускаринового рецептора.Methods and compositions for treating conditions associated with the collapse of the pharyngeal muscles of the respiratory tract in which the subject is in a state of incomplete consciousness, for example, sleep apnea and snoring, including the administration of a norepinephrine reuptake inhibitor (NRI) and a muscarinic receptor antagonist.

EA201992569A 2017-09-14 2018-04-26 METHODS AND COMPOSITIONS FOR TREATING APNEA IN SLEEP EA201992569A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762558814P 2017-09-14 2017-09-14
PCT/US2018/029518 WO2018200775A1 (en) 2017-04-28 2018-04-26 Methods and compositions for treating sleep apnea

Publications (1)

Publication Number Publication Date
EA201992569A1 true EA201992569A1 (en) 2020-04-10

Family

ID=70483866

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201992569A EA201992569A1 (en) 2017-09-14 2018-04-26 METHODS AND COMPOSITIONS FOR TREATING APNEA IN SLEEP

Country Status (1)

Country Link
EA (1) EA201992569A1 (en)

Similar Documents

Publication Publication Date Title
PH12019502427A1 (en) Methods and compositions for treating sleep apnea
JP2018184462A5 (en)
EA202192202A1 (en) METHODS AND COMPOSITIONS FOR TREATMENT OF OBSTRUCTIVE APNEA SYNDROME ARISING IN SLEEP
UY37328A (en) SUBSTITUTED DIAZAHETEROBICYCLIC COMPOUNDS AND THEIR USE
EA202091597A1 (en) METHODS AND COMPOSITIONS FOR TREATMENT OF SLEEP APNEA
DOP2019000171A (en) FORMS OF PHARMACEUTICAL ADMINISTRATION CONTAINING INHIBITORS OF TASK-1 AND TASK-3 CHANNELS AND THEIR USE FOR THE TREATMENT OF RESPIRATORY DISORDERS
DOP2019000172A (en) FORMS OF PHARMACEUTICAL ADMINISTRATION CONTAINING INHIBITORS OF TASK-1 AND TASK-3 CHANNELS AND THEIR USE FOR THE TREATMENT OF RESPIRATORY DISORDERS
WO2014120936A3 (en) Treatments for depression and other diseases with a low dose agent
JOP20210059A1 (en) ?2-Adrenoceptor subtype C (alpha-2C) antagonists for the treatment of sleep apnea
CL2023002824A1 (en) Methods and compositions to treat sleep apnea
EA201992569A1 (en) METHODS AND COMPOSITIONS FOR TREATING APNEA IN SLEEP
MX2021001845A (en) A combination medicament comprising phenylephrine and paracetamol.
WO2015059638A3 (en) Cns stimulant and opioid receptor antagonist combination as a non- addictive, non-aversive and synergistic anti-obesity treatment
EA201991417A1 (en) NEW MEDICINAL FORMS WITH IMMEDIATE AND MODIFIED REMEDIES FOR ORAL USE CONTAINING TIBIPEN PEVOXYL
NZ758564B2 (en) Methods and compositions for treating sleep apnea
JOP20210113A1 (en) ?2-Adrenoceptor subtype C (alpha-2C) antagonists for the treatment of sleep apnea
EA201991538A1 (en) PHARMACEUTICAL DOSAGE FORMS CONTAINING TASK-1 AND TASK-3 CHANNEL INHIBITORS AND THEIR APPLICATION FOR TREATMENT OF RESPIRATORY DISORDERS
EA201990341A1 (en) SUBSTITUTED DIAZAHETEROBICYCLIC COMPOUNDS AND THEIR APPLICATION
TR201716238A1 (en) New pharmaceutical compositions.
CN302529396S (en) High Waist Abdominal Seamless Pantyhose